CVE:LTY Liberty Biopharma (LTY) Stock Forecast, Price & News C$2.00 +2.00 (+∞) (As of 10/10/2018) Add Compare Share Share Today's RangeC$2.00▼C$2.0050-Day RangeC$2.00▼C$2.0052-Week RangeC$0.06▼C$2.74Volume700 shsAverage Volume23,286 shsMarket CapitalizationC$21.54 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileChartCompetitorsInsider TradesHeadlinesProfileChartCompetitorsInsider TradesHeadlines About Liberty Biopharma (CVE:LTY) StockLiberty Biopharma Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease. The company was formerly known as Avagenesis Corp. and changed its name to Liberty Biopharma Inc. in January 2017. Liberty Biopharma Inc. is based in Richmond, Canada.Read More Receive LTY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Liberty Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address LTY Stock News HeadlinesMay 21, 2023 | americanbankingnews.comLiberty Biopharma (CVE:LTY) Share Price Crosses Below Two Hundred Day Moving Average of $2.00May 21, 2023 | msn.comWash Out; Liberty Hexed by Mystics in 2023 DebutMay 30, 2023 | Edge On The Street (Ad)Is Graphite the New Lithium?Did you know that graphite (NOT lithium) is the largest component of lithium batteries used for EV's? Unfortunately, there are no graphite-producing mines in North America today. This leaves the U.S. at the mercy of China for our vital graphite supply.May 17, 2023 | marketwatch.comLIBERTY SPORTS GROUP PARTNERS WITH CHEQ TO ELEVATE THE GAMEDAY EXPERIENCEMay 15, 2023 | benzinga.com9 Meters Biopharma Provides Business Update and Reports Financial Results for First Quarter 2023May 14, 2023 | investing.comIntech Biopharm Ltd (6461)May 13, 2023 | investing.comLiberty Defense Holdings Ltd (LDDFF)May 12, 2023 | investing.comLepu Biopharma Co Ltd (2157)May 30, 2023 | Edge On The Street (Ad)Is Graphite the New Lithium?Did you know that graphite (NOT lithium) is the largest component of lithium batteries used for EV's? Unfortunately, there are no graphite-producing mines in North America today. This leaves the U.S. at the mercy of China for our vital graphite supply.May 11, 2023 | msn.comWhy CTI BioPharma Shares Are Trading Higher By 84%; Here Are 20 Stocks Moving PremarketMay 10, 2023 | finanznachrichten.deYS BIOPHARMA CO LTDMay 9, 2023 | benzinga.comLiberty TripAdvisor Holdings, Inc. to Hold Virtual Annual Meeting of StockholdersMay 8, 2023 | forbes.comLiberty Mutual Pet Insurance Review 2023May 8, 2023 | reuters.comBaxter to divest biopharma business for $4.25 billionMay 3, 2023 | marketwatch.comMicrobot Medical's LIBERTY(R) Robotic System Surpasses 100th CatheterizationApril 30, 2023 | msn.comLiberty boosts its life unit with Sh130 million capitalApril 25, 2023 | msn.comXeris Biopharma Holdings (STU:2B30) Price Target Decreased by 7.84% to 4.33April 20, 2023 | msn.comLiberty Water Invests $265 Million In Last 5 Years For InfrastructureApril 14, 2023 | forbes.comLiberty Home Guard Review 2023April 9, 2023 | americanbankingnews.comLiberty Biopharma (CVE:LTY) Stock Crosses Below 200 Day Moving Average of $2.00February 28, 2023 | msn.comExplore Two American Landmarks When You Visit The Statue Of Liberty & Ellis Island In New YorkFebruary 26, 2023 | msn.comGuide to Visiting the Statue of LibertyFebruary 9, 2023 | yahoo.com'Moms for Liberty' calls on lawmakers to help get 'inappropriate' books out of Iowa schoolsFebruary 7, 2023 | yahoo.com'Moms for Liberty' calls for lawmakers to get 'inappropriate' books out of Iowa schoolsFebruary 2, 2023 | msn.comLiberty Twp. Hampton Inn sold to S.C. companyJanuary 27, 2023 | bizjournals.comSale price leaps by $20M for repurposed Durham warehouseNovember 1, 2022 | msn.comHow a Maryland ‘Moms for Liberty' group became leaders in our country's culture warSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive LTY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Liberty Biopharma and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCVE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolCVE:LTY Previous SymbolCVE:VVA CUSIPN/A CIKN/A Webwww.libertybiopharma.com Phone+1-604-3777575FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio8.19 Current Ratio0.12 Quick Ratio0.12 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowC$0.00 per share Price / Cash Flow2,000.00 Book ValueC$0.79 per share Price / Book2.53Miscellaneous Outstanding Shares10,770,000Free FloatN/AMarket CapC$21.54 million OptionableNot Optionable BetaN/A Key ExecutivesMr. Norman Tsui (Age 45)Pres, CEO & Director Mr. Shui Yan Tam (Age 44)Chief Financial Officer Dr. Michael T. McNamaraMedical Advisor & DirectorDr. Richard Huang Ph.D. (Age 42)Chief Technology Officer Dr. Richard Cook M.D.Msc., FRCSC, Chief Medical OfficerKey CompetitorsIBEX TechnologiesCVE:IBTDevonian Health GroupCVE:GSDSmall PharmaCVE:DMTAntibe TherapeuticsTSE:ATEAcasti PharmaCVE:ACSTView All Competitors LTY Stock - Frequently Asked Questions How have LTY shares performed in 2023? Liberty Biopharma's stock was trading at C$2.00 at the beginning of the year. Since then, LTY stock has increased by 0.0% and is now trading at C$2.00. View the best growth stocks for 2023 here. What other stocks do shareholders of Liberty Biopharma own? Based on aggregate information from My MarketBeat watchlists, some companies that other Liberty Biopharma investors own include Cross Timbers Royalty Trust (CRT), InfraCap MLP ETF (AMZA), Alliance Resource Partners (ARLP), Brigham Minerals (MNRL), Arbor Realty Trust (ABR), Advanced Emissions Solutions (ADES), Archer-Daniels-Midland (ADM), AGNC Investment (AGNC) and AMC Entertainment (AMC). What is Liberty Biopharma's stock symbol? Liberty Biopharma trades on the Canadian Venture Exchange (CVE) under the ticker symbol "LTY." How do I buy shares of Liberty Biopharma? Shares of LTY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.Compare Top Brokerages Here. What is Liberty Biopharma's stock price today? One share of LTY stock can currently be purchased for approximately C$2.00. How much money does Liberty Biopharma make? Liberty Biopharma (CVE:LTY) has a market capitalization of C$21.54 million. How can I contact Liberty Biopharma? Liberty Biopharma's mailing address is 2270-8788 McKim Way, RICHMOND, BC V6X 4E2, Canada. The official website for the company is www.libertybiopharma.com. The biotechnology company can be reached via phone at +1-604-3777575. This page (CVE:LTY) was last updated on 5/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Liberty Biopharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.